The spatio-temporal characteristics of grey matter (GM) impairment in multiple sclerosis (MS) are poorly understood. We used a new surface-based diffusion MRI processing tool to investigate regional modifications of microstructure, and we quantified volume loss in GM in a cohort of patients with MS classified into three groups according to disease duration. Additionally, we investigated the relationship between GM changes with disease severity. We studied 54 healthy controls and 247 MS patients classified regarding disease duration: MS1 (less than 5 years, n = 67); MS2 (5–15 years, n = 107); and MS3 (more than15 years, n = 73). We compared GM mean diffusivity (MD), fractional anisotropy (FA) and volume between groups, and estimated their cl...
Objectives. Grey matter (GM) involvement is clinically relevant in multiple sclerosis (MS). Using so...
OBJECTIVE: Gray matter (GM) atrophy occurs in all multiple sclerosis (MS) phenotypes. We investigate...
Gray matter (GM) atrophy occurs in all multiple sclerosis (MS) phenotypes. We investigated whether t...
Altres ajuts: Fondo Europeo de Desarrollo Regional (FEDER, "Otra manera de hacer Europa", "Investing...
peer reviewedDespite robust postmortem evidence and potential clinical importance of gray matter (GM...
Deep gray matter involvement is a consistent feature in multiple sclerosis. The aim of this study wa...
BACKGROUND AND PURPOSE: Increasing evidence exists that cerebral gray matter (GM) from patients with...
AbstractGrey matter (GM) atrophy occurs early in primary progressive MS (PPMS), but it is unknown wh...
The mechanisms underlying the progressive course of multiple sclerosis (MS) are not fully understood...
AbstractDTI studies in multiple sclerosis (MS) reveal white matter (WM) injury that occurs with dise...
Objective: Gray matter (GM) atrophy occurs in all multiple sclerosis (MS) phenotypes. We investigate...
Background: In multiple sclerosis (MS), demyelination and neuro-axonal loss occur in the brain ...
BACKGROUND:Both gray-matter (GM) atrophy and lesions occur from the earliest stages of Multiple Scle...
Cognitive decline is a prominent symptom of MS. Clear connection between cognitive status and white ...
Introduction: Gray matter (GM) atrophy is common in multiple sclerosis (MS), but the relationship wi...
Objectives. Grey matter (GM) involvement is clinically relevant in multiple sclerosis (MS). Using so...
OBJECTIVE: Gray matter (GM) atrophy occurs in all multiple sclerosis (MS) phenotypes. We investigate...
Gray matter (GM) atrophy occurs in all multiple sclerosis (MS) phenotypes. We investigated whether t...
Altres ajuts: Fondo Europeo de Desarrollo Regional (FEDER, "Otra manera de hacer Europa", "Investing...
peer reviewedDespite robust postmortem evidence and potential clinical importance of gray matter (GM...
Deep gray matter involvement is a consistent feature in multiple sclerosis. The aim of this study wa...
BACKGROUND AND PURPOSE: Increasing evidence exists that cerebral gray matter (GM) from patients with...
AbstractGrey matter (GM) atrophy occurs early in primary progressive MS (PPMS), but it is unknown wh...
The mechanisms underlying the progressive course of multiple sclerosis (MS) are not fully understood...
AbstractDTI studies in multiple sclerosis (MS) reveal white matter (WM) injury that occurs with dise...
Objective: Gray matter (GM) atrophy occurs in all multiple sclerosis (MS) phenotypes. We investigate...
Background: In multiple sclerosis (MS), demyelination and neuro-axonal loss occur in the brain ...
BACKGROUND:Both gray-matter (GM) atrophy and lesions occur from the earliest stages of Multiple Scle...
Cognitive decline is a prominent symptom of MS. Clear connection between cognitive status and white ...
Introduction: Gray matter (GM) atrophy is common in multiple sclerosis (MS), but the relationship wi...
Objectives. Grey matter (GM) involvement is clinically relevant in multiple sclerosis (MS). Using so...
OBJECTIVE: Gray matter (GM) atrophy occurs in all multiple sclerosis (MS) phenotypes. We investigate...
Gray matter (GM) atrophy occurs in all multiple sclerosis (MS) phenotypes. We investigated whether t...